Myasthenia gravis trials in France

In France 23 Also abroad 123

23 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
Where
Bordeaux, Marseille, Nantes, Nice
Age
18 years and over
People
59 worldwide
Run by
NMD Pharma A/S
See details and how to join2023-507539-40-00 · EU 2023-507539-40-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Where
Dijon, Lille Cedex, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Toulouse
Age
18 years and over
People
120 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT07463521 · EU 2025-524756-54-00
Phase 3Taking people
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Where
Dijon, Lille Cedex, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Toulouse
Age
18 years and over
People
100 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT07465289 · EU 2025-524757-14-00
Phase 3Taking people
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Where
Bron, Nice, Paris Cedex 13
Age
18 years and over
People
199 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT04951622 · EU 2023-504152-97-00
No phaseTaking people
Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360
Where
Brest, Garches, Nancy, Nantes, Nice, Strasbourg, Toulouse
Age
18 years and over
People
100 worldwide
Run by
Ad scientiam
See details and how to joinNCT07323316
Phase 2/3Enrolling by invitation
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
Where
Marseille, Paris
Age
2 years to 18 years
People
12 worldwide
Run by
argenx
See details and how to joinNCT05374590 · EU 2023-507379-23-00
Phase 3Taking people
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Where
Garches, Nice, Paris
Age
18 years to 80 years
People
195 worldwide
Run by
Dianthus Therapeutics
See details and how to joinNCT07647510 · EU 2026-525298-38-00
Phase 2Taking people
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Where
Paris
Age
2 years to 17 years
People
15 worldwide
Run by
Amgen
See details and how to joinNCT06987539 · EU 2025-520993-20-00
Phase 3Taking people
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Where
Bron, Clermont-Ferrand, Creteil, Grenoble Cedex 9, Lille Cedex, Nice, Paris, Paris Cedex 13, Strasbourg Cedex 2
Age
18 years and over
People
264 worldwide
Run by
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
See details and how to joinNCT06463587 · EU 2023-507746-83-00
Phase 2/3Taking people
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Where
Marseille
Age
2 years to 17 years
People
12 worldwide
Run by
argenx
See details and how to joinNCT06392386 · EU 2023-506159-12-00
Phase 4Taking people
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
Where
Créteil, Garches, Grenoble, Lille, Marseille, Nancy, Nice, Rouen, Toulouse
Age
65 years and over
People
50
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07072988
No phaseTaking people
Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis
Where
Bron, Garches, Le Kremlin-Bicêtre, Lille, Marseille, Nice, Strasbourg, Toulouse
Age
18 years and over
People
30
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07411963
No phaseTaking people
Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)
Where
Angers, Boulogne-sur-Mer, Créteil, Garches, Grenoble, Lille, Limoges, Nice, Rouen, Toulouse
Age
18 years and over
People
50
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07570589
Phase 2Taking people
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Where
Bordeaux, Marseille, Nantes, Nice
Age
18 years and over
People
84 worldwide
Run by
NMD Pharma A/S
See details and how to joinNCT06414954
No phaseNot yet taking people in France
Sexual and Urinary Dysfunctions in Generalized Myasthenia
Where
Nice, Paris
Age
18 years and over
People
150
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07677852
No phaseTaking people
Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
Where
Paris
Age
18 years and over
People
50
Run by
Institut de Myologie, France
See details and how to joinNCT06866652
No phaseTaking people
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Where
Paris
People
75 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644
Phase 3Taking people
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
Where
Bordeaux, Garches, Lille, Lyon, Nice, Paris, Strasbourg, Toulouse
Age
18 years and over
People
128
Run by
Fondation Ophtalmologique Adolphe de Rothschild
See details and how to joinNCT06342544
No phaseTaking people
Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
Where
Nice
Age
18 years and over
People
55
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT06815133
No phaseNot yet taking people in France
Integrating Art Therapy and Adapted Physical Activity: Toward Improved Quality of Life in Patients With Myasthenia Gravis
Where
Lille
Age
18 years and over
People
102
Run by
Universite du Littoral Cote d'Opale
See details and how to joinNCT07125105
Phase 3Taking people
Immediate corticosteroid therapy and rituximab to prevent generalization in ocular myasthenia gravis: a PROBE-type multicenter, open-label, randomized controlled trial
Where
Bordeaux, Bron, Garches, Lille Cedex, Nice, Paris, Paris Cedex 13, Strasbourg Cedex 2, Toulouse
Age
18 years and over
People
128
Run by
Hopital Fondation Adolphe De Rothschild
See details and how to join2023-506656-24-00 · EU 2023-506656-24-00
No phaseTaking people
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
Where
Garches, Grenoble, Lille, Nancy, Nantes, Paris, Strasbourg, Toulouse
Age
18 years and over
People
144 worldwide
Run by
Ad scientiam
See details and how to joinNCT05564936
No phaseEnrolling by invitation
Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
Where
Clermont-Ferrand
Age
18 years and over
People
100
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT06877403